Analisi costo-beneficio

Vaccinazione anti-rotavirus: intervento lodevole ma… fa risparmiare il Sistema Sanitario Nazionale? L’esperienza del Brasile

C. Centenari, G. Maggiore, R.Q. Gurgel, L.E. Cuevas

2011/3

The present “budget impact” study assessed the family and health system costs due to diarrhoea in children < 2 years old, before/after the introduction of a rotavirus vaccine in Brazil in 2006. This kind of evaluations plays a crucial role in the ass...

Vaccinazione anti-varicellaAsma, steroidi inalatori e guaribilitàEmergency

2006/4 — pag. 217-221

Costi-benefici dei vaccini antipertosse acellulari e anti-Hib

G. Bartolozzi

1997/1 — pag. 35-40

The Author proposes a cost/benefit analysis for pertussis and haemophilus type b vaccines. Cost/benefit of the new acellular pertussis vaccines is higher than for the wholecell vaccines due to the higher cost of the former, but better acceptance...

La vaccinazione contro il Rotavirus

G. Palla, A. Ventura

1997/1 — pag. 29-33

Rotavirus is the leading cause of severe diarrhoea in infants and causes an estimated 900.000 deaths annually in developing countries. In developed cauntries the rate of hospital admission for Rotavirus gastroenteritis is 3-10/1000 childrens age...